Selected research
Industry Research
Umbilical Cord Blood and Tissue Storage Service Industry Research Report 2026
Market perspective
The global Umbilical Cord Blood and Tissue Storage Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Umbilical Cord Blood and Tissue Storage Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Umbilical Cord Blood and Tissue Storage Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Umbilical Cord Blood and Tissue Storage Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Umbilical Cord Blood and Tissue Storage Service include Americord Registry, Cord For Life, MiracleCord, Stemcyte, Cenbest, Famicord Group, Anja Health, Smart Cells and Cells4Life, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Umbilical Cord Blood and Tissue Storage Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Umbilical Cord Blood and Tissue Storage Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Umbilical Cord Blood and Tissue Storage Service Market by Company
Americord Registry
Cord For Life
MiracleCord
Stemcyte
Cenbest
Famicord Group
Anja Health
Smart Cells
Cells4Life
Chinacord
Landfarbio Group
Yuanpin Bio
Qilu Cellbank
Cordlife
StemCell Institute
MEDIPOST
Cord Blood Registry
Cryo-Cell
ViaCord
Umbilical Cord Blood and Tissue Storage Service Segment by Type
Private Banks
Public Banks
Mixed Banks
Umbilical Cord Blood and Tissue Storage Service Segment by Application
Blood Diseases
Immune Diseases
Nervous System Diseases
Genetic Metabolic Diseases
Congenital Diseases
Others
Umbilical Cord Blood and Tissue Storage Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Umbilical Cord Blood and Tissue Storage Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Umbilical Cord Blood and Tissue Storage Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Umbilical Cord Blood and Tissue Storage Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Umbilical Cord Blood and Tissue Storage Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Private Banks
- Public Banks
- Mixed Banks
Applications
- Blood Diseases
- Immune Diseases
- Nervous System Diseases
- Genetic Metabolic Diseases
- Congenital Diseases
- Others
Companies covered
- Americord Registry
- Cord For Life
- MiracleCord
- Stemcyte
- Cenbest
- Famicord Group
- Anja Health
- Smart Cells
- Cells4Life
- Chinacord
- Landfarbio Group
- Yuanpin Bio
- Qilu Cellbank
- Cordlife
- StemCell Institute
- MEDIPOST
- Cord Blood Registry
- Cryo-Cell
- ViaCord
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Umbilical Cord Blood and Tissue Storage Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Private Banks
- 2.2.3 Public Banks
- 2.2.4 Mixed Banks
- 2.3 Umbilical Cord Blood and Tissue Storage Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Blood Diseases
- 2.3.3 Immune Diseases
- 2.3.4 Nervous System Diseases
- 2.3.5 Genetic Metabolic Diseases
- 2.3.6 Congenital Diseases
- 2.3.7 Others
- 2.4 Assumptions and Limitations
3 Umbilical Cord Blood and Tissue Storage Service Breakdown Data by Type
- 3.1 Global Umbilical Cord Blood and Tissue Storage Service Historic Market Size by Type (2021-2026)
- 3.2 Global Umbilical Cord Blood and Tissue Storage Service Forecasted Market Size by Type (2027-2032)
4 Umbilical Cord Blood and Tissue Storage Service Breakdown Data by Application
- 4.1 Global Umbilical Cord Blood and Tissue Storage Service Historic Market Size by Application (2021-2026)
- 4.2 Global Umbilical Cord Blood and Tissue Storage Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Umbilical Cord Blood and Tissue Storage Service Market Perspective (2021-2032)
- 5.2 Global Umbilical Cord Blood and Tissue Storage Service Growth Trends by Region
- 5.2.1 Global Umbilical Cord Blood and Tissue Storage Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Umbilical Cord Blood and Tissue Storage Service Historic Market Size by Region (2021-2026)
- 5.2.3 Umbilical Cord Blood and Tissue Storage Service Forecasted Market Size by Region (2027-2032)
- 5.3 Umbilical Cord Blood and Tissue Storage Service Market Dynamics
- 5.3.1 Umbilical Cord Blood and Tissue Storage Service Industry Trends
- 5.3.2 Umbilical Cord Blood and Tissue Storage Service Market Drivers
- 5.3.3 Umbilical Cord Blood and Tissue Storage Service Market Challenges
- 5.3.4 Umbilical Cord Blood and Tissue Storage Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Umbilical Cord Blood and Tissue Storage Service Players by Revenue
- 6.1.1 Global Top Umbilical Cord Blood and Tissue Storage Service Players by Revenue (2021-2026)
- 6.1.2 Global Umbilical Cord Blood and Tissue Storage Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Umbilical Cord Blood and Tissue Storage Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Umbilical Cord Blood and Tissue Storage Service Head Office and Area Served
- 6.4 Global Umbilical Cord Blood and Tissue Storage Service Players, Product Type & Application
- 6.5 Global Umbilical Cord Blood and Tissue Storage Service Manufacturers Established Date
- 6.6 Global Umbilical Cord Blood and Tissue Storage Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Umbilical Cord Blood and Tissue Storage Service Market Size (2021-2032)
- 7.2 North America Umbilical Cord Blood and Tissue Storage Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Umbilical Cord Blood and Tissue Storage Service Market Size by Country (2021-2026)
- 7.4 North America Umbilical Cord Blood and Tissue Storage Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Umbilical Cord Blood and Tissue Storage Service Market Size (2021-2032)
- 8.2 Europe Umbilical Cord Blood and Tissue Storage Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Umbilical Cord Blood and Tissue Storage Service Market Size by Country (2021-2026)
- 8.4 Europe Umbilical Cord Blood and Tissue Storage Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Umbilical Cord Blood and Tissue Storage Service Market Size (2021-2032)
- 9.2 Asia-Pacific Umbilical Cord Blood and Tissue Storage Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Umbilical Cord Blood and Tissue Storage Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Umbilical Cord Blood and Tissue Storage Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Umbilical Cord Blood and Tissue Storage Service Market Size (2021-2032)
- 10.2 South America Umbilical Cord Blood and Tissue Storage Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Umbilical Cord Blood and Tissue Storage Service Market Size by Country (2021-2026)
- 10.4 South America Umbilical Cord Blood and Tissue Storage Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Umbilical Cord Blood and Tissue Storage Service Market Size (2021-2032)
- 11.2 Middle East & Africa Umbilical Cord Blood and Tissue Storage Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Umbilical Cord Blood and Tissue Storage Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Umbilical Cord Blood and Tissue Storage Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Americord Registry
- 12.1.1 Americord Registry Company Information
- 12.1.2 Americord Registry Business Overview
- 12.1.3 Americord Registry Revenue in Umbilical Cord Blood and Tissue Storage Service Business (2021-2026)
- 12.1.4 Americord Registry Umbilical Cord Blood and Tissue Storage Service Product Portfolio
- 12.1.5 Americord Registry Recent Developments
- 12.2 Cord For Life
- 12.2.1 Cord For Life Company Information
- 12.2.2 Cord For Life Business Overview
- 12.2.3 Cord For Life Revenue in Umbilical Cord Blood and Tissue Storage Service Business (2021-2026)
- 12.2.4 Cord For Life Umbilical Cord Blood and Tissue Storage Service Product Portfolio
- 12.2.5 Cord For Life Recent Developments
- 12.3 MiracleCord
- 12.3.1 MiracleCord Company Information
- 12.3.2 MiracleCord Business Overview
- 12.3.3 MiracleCord Revenue in Umbilical Cord Blood and Tissue Storage Service Business (2021-2026)
- 12.3.4 MiracleCord Umbilical Cord Blood and Tissue Storage Service Product Portfolio
- 12.3.5 MiracleCord Recent Developments
- 12.4 Stemcyte
- 12.4.1 Stemcyte Company Information
- 12.4.2 Stemcyte Business Overview
- 12.4.3 Stemcyte Revenue in Umbilical Cord Blood and Tissue Storage Service Business (2021-2026)
- 12.4.4 Stemcyte Umbilical Cord Blood and Tissue Storage Service Product Portfolio
- 12.4.5 Stemcyte Recent Developments
- 12.5 Cenbest
- 12.5.1 Cenbest Company Information
- 12.5.2 Cenbest Business Overview
- 12.5.3 Cenbest Revenue in Umbilical Cord Blood and Tissue Storage Service Business (2021-2026)
- 12.5.4 Cenbest Umbilical Cord Blood and Tissue Storage Service Product Portfolio
- 12.5.5 Cenbest Recent Developments
- 12.6 Famicord Group
- 12.6.1 Famicord Group Company Information
- 12.6.2 Famicord Group Business Overview
- 12.6.3 Famicord Group Revenue in Umbilical Cord Blood and Tissue Storage Service Business (2021-2026)
- 12.6.4 Famicord Group Umbilical Cord Blood and Tissue Storage Service Product Portfolio
- 12.6.5 Famicord Group Recent Developments
- 12.7 Anja Health
- 12.7.1 Anja Health Company Information
- 12.7.2 Anja Health Business Overview
- 12.7.3 Anja Health Revenue in Umbilical Cord Blood and Tissue Storage Service Business (2021-2026)
- 12.7.4 Anja Health Umbilical Cord Blood and Tissue Storage Service Product Portfolio
- 12.7.5 Anja Health Recent Developments
- 12.8 Smart Cells
- 12.8.1 Smart Cells Company Information
- 12.8.2 Smart Cells Business Overview
- 12.8.3 Smart Cells Revenue in Umbilical Cord Blood and Tissue Storage Service Business (2021-2026)
- 12.8.4 Smart Cells Umbilical Cord Blood and Tissue Storage Service Product Portfolio
- 12.8.5 Smart Cells Recent Developments
- 12.9 Cells4Life
- 12.9.1 Cells4Life Company Information
- 12.9.2 Cells4Life Business Overview
- 12.9.3 Cells4Life Revenue in Umbilical Cord Blood and Tissue Storage Service Business (2021-2026)
- 12.9.4 Cells4Life Umbilical Cord Blood and Tissue Storage Service Product Portfolio
- 12.9.5 Cells4Life Recent Developments
- 12.10 Chinacord
- 12.10.1 Chinacord Company Information
- 12.10.2 Chinacord Business Overview
- 12.10.3 Chinacord Revenue in Umbilical Cord Blood and Tissue Storage Service Business (2021-2026)
- 12.10.4 Chinacord Umbilical Cord Blood and Tissue Storage Service Product Portfolio
- 12.10.5 Chinacord Recent Developments
- 12.11 Landfarbio Group
- 12.11.1 Landfarbio Group Company Information
- 12.11.2 Landfarbio Group Business Overview
- 12.11.3 Landfarbio Group Revenue in Umbilical Cord Blood and Tissue Storage Service Business (2021-2026)
- 12.11.4 Landfarbio Group Umbilical Cord Blood and Tissue Storage Service Product Portfolio
- 12.11.5 Landfarbio Group Recent Developments
- 12.12 Yuanpin Bio
- 12.12.1 Yuanpin Bio Company Information
- 12.12.2 Yuanpin Bio Business Overview
- 12.12.3 Yuanpin Bio Revenue in Umbilical Cord Blood and Tissue Storage Service Business (2021-2026)
- 12.12.4 Yuanpin Bio Umbilical Cord Blood and Tissue Storage Service Product Portfolio
- 12.12.5 Yuanpin Bio Recent Developments
- 12.13 Qilu Cellbank
- 12.13.1 Qilu Cellbank Company Information
- 12.13.2 Qilu Cellbank Business Overview
- 12.13.3 Qilu Cellbank Revenue in Umbilical Cord Blood and Tissue Storage Service Business (2021-2026)
- 12.13.4 Qilu Cellbank Umbilical Cord Blood and Tissue Storage Service Product Portfolio
- 12.13.5 Qilu Cellbank Recent Developments
- 12.14 Cordlife
- 12.14.1 Cordlife Company Information
- 12.14.2 Cordlife Business Overview
- 12.14.3 Cordlife Revenue in Umbilical Cord Blood and Tissue Storage Service Business (2021-2026)
- 12.14.4 Cordlife Umbilical Cord Blood and Tissue Storage Service Product Portfolio
- 12.14.5 Cordlife Recent Developments
- 12.15 StemCell Institute
- 12.15.1 StemCell Institute Company Information
- 12.15.2 StemCell Institute Business Overview
- 12.15.3 StemCell Institute Revenue in Umbilical Cord Blood and Tissue Storage Service Business (2021-2026)
- 12.15.4 StemCell Institute Umbilical Cord Blood and Tissue Storage Service Product Portfolio
- 12.15.5 StemCell Institute Recent Developments
- 12.16 MEDIPOST
- 12.16.1 MEDIPOST Company Information
- 12.16.2 MEDIPOST Business Overview
- 12.16.3 MEDIPOST Revenue in Umbilical Cord Blood and Tissue Storage Service Business (2021-2026)
- 12.16.4 MEDIPOST Umbilical Cord Blood and Tissue Storage Service Product Portfolio
- 12.16.5 MEDIPOST Recent Developments
- 12.17 Cord Blood Registry
- 12.17.1 Cord Blood Registry Company Information
- 12.17.2 Cord Blood Registry Business Overview
- 12.17.3 Cord Blood Registry Revenue in Umbilical Cord Blood and Tissue Storage Service Business (2021-2026)
- 12.17.4 Cord Blood Registry Umbilical Cord Blood and Tissue Storage Service Product Portfolio
- 12.17.5 Cord Blood Registry Recent Developments
- 12.18 Cryo-Cell
- 12.18.1 Cryo-Cell Company Information
- 12.18.2 Cryo-Cell Business Overview
- 12.18.3 Cryo-Cell Revenue in Umbilical Cord Blood and Tissue Storage Service Business (2021-2026)
- 12.18.4 Cryo-Cell Umbilical Cord Blood and Tissue Storage Service Product Portfolio
- 12.18.5 Cryo-Cell Recent Developments
- 12.19 ViaCord
- 12.19.1 ViaCord Company Information
- 12.19.2 ViaCord Business Overview
- 12.19.3 ViaCord Revenue in Umbilical Cord Blood and Tissue Storage Service Business (2021-2026)
- 12.19.4 ViaCord Umbilical Cord Blood and Tissue Storage Service Product Portfolio
- 12.19.5 ViaCord Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst